Technical note – Capturing accurate single-molecule FRET measurements on the EI-FLEX system

Format

Technical note

In this technical note, we explore several key components of a confocal FRET experiment that ensure single-molecule sensitivity and accurate determination of FRET efficiencies, taking into account the influence of inefficient labelling of target molecules and photophysical artefacts. Ensuring these factors are corrected during data acquisition and analysis allows resolution of complex subpopulations, conformational changes and nanoscale measurements that can be reported with confidence.

Overview of this application note:

  • How confocal volumes can achieve single-molecule sensitivity
  • The use of alternating laser excitation (ALEX) and burst searching to identify doubly labelled molecules and photophysical artefacts
  • How accurate FRET correction is performed using ALEX
Capturing accurate single-molecule FRET measurements on the EI-FLEX platform using ALEX in a confocal volume

Figure 1 – Confocal volume for smFRET

Single molecules diffuse through a confocal volume formed by focusing lasers to a near diffraction-limited spot. Lasers are alternated rapidly (20 KHz) to ensure each molecule experiences multiple periods of donor and acceptor excitation, respectively.

Recent posts

Discover how fluorescence cross-correlation spectroscopy (FCCS) can simplify ternary complex analysis in drug discovery. This practical handbook explores in-solution measurement of complex formation, hook effects, cooperativity and stability, with real-world workflows for targeted protein degradation and multi-specific biologics.
In this press release, we announce the launch of the PhotonFit analysis software, a streamlined software platform designed to remove long-standing technical barriers to smFRET, FCS, and FCCS data processing.
Discover how solution-phase single-molecule techniques (smFRET, FCS, FCCS) bridge structural biology with kinetic mechanisms across nutrient sensing, viral replication, and therapeutic antibody targeting.